(238)Pu elimination profiles after delayed treatment with 3,4,3LI(1,2HOPO) in female and male Swiss-Webster mice.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

To characterize the dose-dependent and sex-related efficacy of the hydroxypyridinonate decorporation agent 3,4,3-LI(1,2-HOPO) at enhancing plutonium elimination when post-exposure treatment is delayed.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Int. J. Radiat. Biol.

Title: International journal of radiation biology

Publisher: Informa UK Limited

ISSN (Electronic): 1362-3095

ISSN (Print): 0955-3002

Publication date (Electronic): Nov 2014

Volume: 90

Issue: 11

Affiliations

[1 ] Chemical Sciences Division, Lawrence Berkeley National Laboratory , Berkeley, California , USA.

Article

DOI: 10.3109/09553002.2014.925150

PubMed ID: 24937372

SO-VID: d11765bf-7f20-4a0c-bc8f-8bc4bbe600bb

History

Keywords: radiation protection,radionuclides,medical countermeasures,plutonium,Alpha emitters,chelation therapy

Data availability:

Keywords: radiation protection, radionuclides, medical countermeasures, plutonium, Alpha emitters, chelation therapy

(238)Pu elimination profiles after delayed treatment with 3,4,3LI(1,2HOPO) in female and male Swiss-Webster mice.

Read this article at

Abstract

Related collections

Chinese Journal of Radiological Health

Author and article information

Journal

Affiliations

Article

History

Comments

Comment on this article

Cited by 4